Undisclosed antiretroviral drug use in a multinational clinical trial (HIV prevention trials network 052)

Journal of Infectious Diseases

Volumn 208, Issue 10, 2013, Pages 1624-1628

  Fogel, Jessica M ^a   Wang, Lei ^b   Parsons, Teresa L ^a   Ou, San San ^b   Piwowar Manning, Estelle ^a   Chen, Ying ^b   Mudhune, Victor O ^g   Hosseinipour, Mina C ^h   Kumwenda, Johnstone ⁱ   Hakim, James G ^j   Chariyalertsak, Suwat ^k   Panchia, Ravindre ^l   Sanne, Ian ^m   Kumarasamy, Nagalingeswaran ⁿ   Grinsztejn, Beatriz ^o   Makhema, Joseph ^r   Pilotto, Jose ^p   Santos, Breno R ^q   Mayer, Kenneth H ^c   McCauley, Marybeth ^d   Gamble, Theresa ^e   Bumpus, Namandjé N ^a   Hendrix, Craig W ^a   Cohen, Myron S ^f   Eshleman, Susan H ^a   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

^c FENWAY INSTITUTE   (United States)

^d FAMILY HEALTH INTERNATIONAL   (United States)

^e FHI 360   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g KEMRI CDC HIV Research Branch   (Kenya)

^h KAMUZU CENTRAL HOSPITAL   (Malawi)

ⁱ UNIVERSITY OF MALAWI   (Malawi)

^j UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^k CHIANG MAI UNIVERSITY   (Thailand)

^l UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^m UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁿ YR Gaitonade Center for AIDS Research and Education   (India)

^o Funda??o Oswaldo Cruz   (Brazil)

^p HOSPITAL GERAL DE FORTALEZA   (Brazil)

^q HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

^r BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

more..

Author keywords

Africa; Antiretroviral drug; Clinical trial; HIV; HPTN 052; Self report

Indexed keywords

AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DARUNAVIR; EFAVIRENZ; EMTRICITABINE; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; NEVIRAPINE PLUS STAVUDINE; NEVIRAPINE PLUS STAVUDINE PLUS ZIDOVUDINE; RITONAVIR; SAQUINAVIR; STAVUDINE; STAVUDINE PLUS ZIDOVUDINE; TENOFOVIR; TIPRANAVIR; UNCLASSIFIED DRUG; ZIDOVUDINE;

ADULT; AFRICA; ARTICLE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SELF REPORT; TREATMENT RESPONSE; VIRUS DETECTION; VIRUS LOAD;

AFRICA; ANTIRETROVIRAL DRUG; CLINICAL TRIAL; HIV; HPTN 052; SELF-REPORT;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; RISK FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84888605119     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit390     Document Type: Article

References (11)

1. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-39.
2. Kahle E, Kashuba A, Baeten J, et al. Unreported antiretroviral use by HIV- 1 infected members of HIV-1 serodiscordant couples enrolling in an HIV-1 prevention clinical trial. In: Proceedings of the International Microbicides Conference; 15-18 April, 2012; Sydney, Australia. Abstract 347.
3. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
4. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367:399-410.
5. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363:2587-99.
6. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367:423-34.
7. Zablotska IB, Prestage G, de Wit J, Grulich AE, Mao L, Holt M. The informal use of antiretrovirals for preexposure prophylaxis of HIV infection among gay men in Australia. JAIDS 2013; 62:334-8.
8. Grelotti DJ, Closson EF, Mimiaga MJ. Pretreatment antiretroviral exposure from recreational use. Lancet Infect Dis 2013; 13:10-2.
9. Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- And street-based populations. Pain Med 2007; 8:171-83.
10. Larkan F, Van Wyk B, Saris J. Of remedies and poisons: recreational use of antiretroviral drugs in the social imagination of South African carers. Afr Sociol Rev 2010; 14:62-73.
11. Marzinke MA, Breaud A, Clarke W. Development of a high resolution accurate mass method for the multiplexed monitoring of antiretroviral agents in human serum. In: Proceedings of the 47th Meeting of the Academy of Clinical Laboratory Physicians and Scientists; 31 May through 2 June, 2012; Milwaukee, WI.